Cogent Biosciences, Inc. (COGT)
39.66
-0.38
(-0.95%)
USD |
NASDAQ |
Dec 12, 09:31
Cogent Biosciences Research and Development Expense (Quarterly): 67.84M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Pfizer Inc. | 2.492B |
| Ionis Pharmaceuticals, Inc. | 217.13M |
| ADMA Biologics, Inc. | 1.528M |
| Editas Medicine, Inc. | 19.05M |
| AnaptysBio, Inc. | 31.27M |